bullous pemphigoid type pemphigoid autoimmune pruritic skin disease typically occurs people aged may involve formation blisters bullae space epidermal dermal skin layers classified type ii hypersensitivity reaction involves formation antihemidesmosome antibodies causing loss keratinocytes basement membrane adhesion clinically earliest lesions may appear hiveslike red raised rash could also appear dermatitic targetoid lichenoid nodular even without rash essential tense bullae eventually erupt commonly inner thighs upper arms trunk extremities frequently involved part skin surface involved oral lesions present minority disease may acute last months years periods exacerbation several skin diseases may similar symptoms however milia common epidermolysis bullosa acquisita deeper antigenic targets ringlike configuration central depression centrally collapsed bullae may indicate linear iga disease nikolskys sign negative unlike pemphigus vulgaris positivecitation cases bullous pemphigoid clear precipitating factors potential precipitating events reported include exposure ultraviolet light radiation onset pemphigoid also associated certain drugs including furosemide nonsteroidal antiinflammatory agents inhibitors captopril penicillamine bullae formed immune reaction initiated formation autoantibodies targeting dystonin also called bullous pemphigoid antigen andor type xvii collagen also called bullous pemphigoid antigen component hemidesmosomes different form dystonin associated following antibody targeting cascade immunomodulators results variable surge immune cells including neutrophils lymphocytes eosinophils coming affected area unclear events subsequently result separation along dermoepidermal junction eventually stretch bullaecitation needed diagnosis consist least positive results criteria rule pruritus andor predominant cutaneous blisters linear igg andor deposits n serrated pattern direct immunofluorescence microscopy dif skin biopsy specimen positive epidermal side staining indirect immunofluorescence microscopy human saltsplit skin iif sss serum routine staining elisa tests add value initial diagnosiscitation needed treatments include topical steroids clobetasol halobetasol studies proven equally effective systemic pill therapy somewhat however difficulttomanage widespread cases systemic prednisone powerful steroidfree immunosuppressant medications methotrexate azathioprine mycophenolate mofetil may medications potential severe adverse effects kidney liver damage increased susceptibility infections bone marrow antibiotics tetracycline erythromycin may also control disease particularly patients use monoclonal antibody rituximab found effective treating otherwise refractory cases updated metaanalysis randomized controlled trials showed oral steroids potent topical steroids effective treatments although use may limited sideeffects lower doses topical steroids safe effective treatment moderate bullous igamediated pemphigoid often difficult treat even usually effective medications bulbous pemphigoid may selfresolving period ranging several months many years even without poor general health related old age associated poorer rarely seen children bullous nonbullous pemphigoid commonly occurs people years age estimated frequency seven cases per million per year reported high cases per million per year scottish men older least one study indicates incidence might increasing united sources report affects men twice frequently others report difference many mammals affected including dogs cats pigs horses well humans rare dogs average three cases diagnosed around world yearcitation needed animal models bullous pemphigoid developed using transgenic techniques produce mice lacking genes two known autoantigens dystonin collagen httpsenwikipediaorgwikibullouspemphigoid